Italia markets closed

Addex Therapeutics Ltd (0QNV.L)

LSE - LSE Prezzo differito. Valuta in CHF.
Aggiungi a watchlist
0,0861-0,1709 (-66,50%)
Alla chiusura: 07:12PM GMT
Schermo intero
Chiusura precedente0,2570
Aperto0,0000
Denaro0,0000 x N/D
Lettera0,0000 x N/D
Min-Max giorno0,0000 - 0,0000
Intervallo di 52 settimane
Volume0
Media Volume140.000
Capitalizzazione23.914
Beta (5 anni mensile)1,68
Rapporto PE (ttm)N/D
EPS (ttm)-0,5260
Prossima data utiliN/D
Rendimento e dividendo (futuro)N/D (N/D)
Data ex dividendoN/D
Stima target 1AN/D
  • GlobeNewswire

    Addex Announces Plan to Implement ADS Ratio Change

    Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, October 6, 2023 - Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, today announced that it plans to change the ratio of its American Depositary Shares (“ADSs”) to its ordinary shares (the “ADS Ratio”) from the current ADS Ratio of one (1) ADS to six (6) ordinary shares to a new ADS Ratio of one (1) ADS to one hundred and twenty (

  • GlobeNewswire

    Addex mGlu2 NAM Cognition Program Receives €4 Million Grant

    Addex led consortium wins Eurostars grant to deliver clinical candidates to treat mild neurocognitive disorders Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, September 20, 2023 - Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, today announced that it has led a consortium which has been awarded a €4 million Eurostars grant to support its metabotropic glutamate 2 (mGlu2) rece

  • GlobeNewswire

    Addex Announces Participation in the H.C. Wainwright 25th Annual Global Investment Conference

    Geneva, Switzerland, September 6, 2023 - Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, today announced that Tim Dyer, Chief Executive Officer, will be attending the H.C. Wainwright 25th Annual Global Investment Conference (September 11 – 13, 2023) in New York. A pre-recorded corporate presentation is scheduled for viewing on Monday, September 11, 2023, at 07:00 EDT. In his presentation, Mr